J. Brodkin

发表

3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity.

Mark Washburn, N. Cosford, L. Bristow, 2003, Journal of medicinal chemistry.

Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity.

N. Cosford, P. Prasit, B. Muñoz, 2004, Journal of medicinal chemistry.

Discovery of novel modulators of metabotropic glutamate receptor subtype-5.

B. Muñoz, M. F. Gardner, Janice Chung, 2004, Bioorganic & medicinal chemistry.

Anxiolytic-like activity of the mGluR5 antagonist MPEP A comparison with diazepam and buspirone

Jesse Brodkin, M. Varney, J. Brodkin, 2002, Pharmacology Biochemistry and Behavior.

5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3'-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity.

Dehua Huang, N. Cosford, B. Muñoz, 2004, Bioorganic & medicinal chemistry letters.

Prenatal Deletion of the RNA-Binding Protein HuD Disrupts Postnatal Cortical Circuit Maturation and Behavior

H. Okano, M. Rasin, Ricardo Azevedo, 2014, The Journal of Neuroscience.

SR141716A antagonizes the disruptive effects of cannabinoid ligands on learning in rats.

J. Brodkin, J. M. Moerschbaecher, 1997, The Journal of pharmacology and experimental therapeutics.

alidation and implementation of a novel high-throughput behavioral henotyping instrument for mice

Maria Gulinello, Christian Gutzen, Ryan M. Grippo, 2014 .

Effect of the R(−) and S(+) isomers of MDA and MDMA on phosphotidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors

D. E. Nichols, B. Roth, J. Brodkin, 1994, Neuroscience Letters.

Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity

J. Brodkin, A. Malyala, J. Nash, 1993, Pharmacology Biochemistry and Behavior.

Reduced stress‐induced hyperthermia in mGluR5 knockout mice

M. Bradbury, L. Bristow, M. Varney, 2002, The European journal of neuroscience.

Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.

J. Brodkin, J. Nash, 1991, The Journal of pharmacology and experimental therapeutics.

A Antagonizes the Disruptive Effects of Cannabinoid Ligands on Learning in Rats 1

J. Brodkin, J. M. Moerschbaecher, 1997 .

Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice.

J. Wess, C. Deng, F. Bymaster, 2001, Life sciences.

Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice.

J. Wess, F. Bymaster, E. Kostenis, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice.

J. Wess, E. Kostenis, A. Grinberg, 1999, Proceedings of the National Academy of Sciences of the United States of America.

GABA-A and 5-HT1A Receptor Agonists Block Expression of Fear-Potentiated Startle in Mice

M. Geyer, V. Risbrough, J. Brodkin, 2003, Neuropsychopharmacology.

Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression

S. Ferguson, F. Menzaghi, J. Brodkin, 2000, Psychopharmacology.

The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of Anxiety

N. Cosford, L. Bristow, Jeffery J. Anderson, 2004, Neuropsychopharmacology.